Travatan and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Travatan (travoprost) and Restoril (temazepam). Common drug interactions include diverticulum intestinal among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Travatan and Restoril. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Travatan?

Travatan has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 13,103 Travatan users. Check the latest studies of Travatan.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 13, 2026

47 people who take Travatan and Restoril together, and have interactions are studied.

Travatan and Restoril drug interactions.

What are the common drug interactions of Travatan and Restoril, by gender? *:

female:

  1. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  2. Dizziness
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
  5. Eyelid ptosis (falling of the upper or lower eyelid)
  6. Fatigue (feeling of tiredness)
  7. Femur fracture
  8. Fistula (an abnormal connection or passageway between two)
  9. Fusobacterium infection (bacterial infection)
  10. Gait disturbance

male:

  1. Anaemia (lack of blood)
  2. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  3. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  4. Nasal discomfort
  5. Pleural effusion (water on the lungs)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Sinusitis (inflammation of sinus)
  8. Arteriovenous fistula site haemorrhage
  9. Blood creatinine increased
  10. Blood urea increased

What are the common drug interactions of Travatan and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Abscess jaw (tooth abscess or root abscess)
  3. Actinic keratosis (skin disease due to sun exposure)
  4. Aggression
  5. Alopecia (absence of hair from areas of the body)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Angina pectoris (chest pain due to ischemia of the heart muscle)
  8. Anxiety
  9. Aortic arteriosclerosis (hardening of the aortic arteries)
  10. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)

50-59:

  1. Chest pain
  2. Death
  3. Hypertensive heart disease
  4. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  5. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  6. Urinary tract infection
  7. Arteriovenous fistula site haemorrhage
  8. Brain stem infarction (brainstem stroke)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Cerebellar infarction (impaired blood circulation to cerebellum)

60+:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Pain
  3. Osteonecrosis of jaw (death of bone of jaw)
  4. Swelling
  5. Tricuspid valve incompetence (inefficient heart valve)
  6. Diarrhoea
  7. Cardiomegaly (increased size of heart than normal)
  8. Rectal haemorrhage (bleeding from anus)
  9. Intervertebral disc degeneration (spinal disc degeneration)
  10. Sinus congestion (blockage of sinus)

What are the existing conditions these people have? *

  1. Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 9 people, 19.15%
  2. Multiple Myeloma (cancer of the plasma cells): 9 people, 19.15%
  3. Pain: 8 people, 17.02%
  4. High Blood Pressure: 8 people, 17.02%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 14.89%
  6. Eye Disorder: 5 people, 10.64%
  7. Migraine (headache): 4 people, 8.51%
  8. Chest Pain: 4 people, 8.51%
  9. Uveitis (inflammation of the uvea): 3 people, 6.38%
  10. Stress And Anxiety: 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Travatan and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Travatan and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Travatan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Travatan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on travoprost and temazepam (the active ingredients of Travatan and Restoril, respectively), and Travatan and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: